CDKN1A and ovarian carcinoma: CDKN1A was highly expressed in cisplatin-sensitive ovarian cancer cell lines, and silencing CDKN1A significantly promoted the proliferation and entry into the cell cycle of cisplatin-sensitive ovarian cancer cells and reduced apoptosis.